News + Filings Transactions
|
Rohlen Douglas
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 21.4k | $41.42 | $888.3k | | 01/26/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Restricted Stock Units | 4.5k | $0.00 | $0 | | 01/26/2021 |
| 08/06/2020 | Eidos Therapeutics, Inc. | EIDX | Grant | Restricted Stock Units | 4.5k | $0.00 | $0 | | 08/06/2020 |
| 08/06/2020 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (Right to Buy) | 21.4k | $41.42 | $888.3k | | 08/06/2020 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Common Stock, $0.001 par value | 9.2k | $24.00 | $221.2k | | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Common Stock, $0.001 par value | 6.8k | $24.00 | $164k | Through D3DC, LLC | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Common Stock, $0.001 par value | 20.3k | $24.00 | $487.2k | Duke Rohlen and Kendall Simpson Rohlen, Trustees or Successor Trustee, of the Rohlen Rev Trust | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Common Stock, $0.001 par value | 4.7k | $24.00 | $112.4k | Through The Rohlen 2013 Irrevocable Trust Agreement | 02/28/2018 |
| 02/28/2018 | ENTELLUS MEDICAL INC | ENTL | Disposition | Stock Option (right to buy) | 7.5k | $17.67 | $132.5k | | 02/28/2018 |
| 07/14/2017 | ENTELLUS MEDICAL INC | ENTL | Grant | Common Stock, $0.001 par value | 3.8k | $0.00 | $0 | | 07/14/2017 |
| 07/14/2017 | ENTELLUS MEDICAL INC | ENTL | Grant | Stock Option (right to buy) | 7.5k | $17.67 | $132.5k | | 07/14/2017 |
|